Treatment of neurodegenerative disease with sodium chlorite
US-2019060359-A1 · Feb 28, 2019 · US
Neuraltus Pharmaceuticals Inc holds 7 patents in our database, with recent filings and technology areas summarized below.
| Metric | Value |
|---|---|
| Total patents | 7 |
| Recent patents | 0 |
| First publication | Feb 5, 2015 |
| Latest publication | Feb 28, 2019 |
Year-over-year patent counts for this assignee.
Latest publications where this party is an assignee.
US-2019060359-A1 · Feb 28, 2019 · US
US-2017106017-A1 · Apr 20, 2017 · US
US-9579346-B2 · Feb 28, 2017 · US
US-2015202185-A1 · Jul 23, 2015 · US
US-9023845-B2 · May 5, 2015 · US
Representative or frequently cited publications from precomputed assignee stats.
US-2019060359-A1 · Feb 28, 2019 · US
US-2017106017-A1 · Apr 20, 2017 · US
US-9579346-B2 · Feb 28, 2017 · US
US-2015202185-A1 · Jul 23, 2015 · US
US-9023845-B2 · May 5, 2015 · US
Most common classification codes in this portfolio.
Mapped technology topics for this assignee.
| Technology | Patents |
|---|---|
| Human Necessities | 7 |
| Chemistry & Metallurgy | 4 |
| Cross-Sectional Technologies | 4 |
| Physics | 3 |
Answers are generated from the same data shown on this page.